Mustang Bio, Inc. · NASDAQ:MBIO
Litchman Manuel MD had 19 Mustang Bio, Inc. shares withheld for tax (Form 4)
Traded Apr 24, 2026 · Filed Apr 27, 2026
On Apr 24, 2026, Litchman Manuel MD (Director, President, CEO and Interim CFO) had 19 Mustang Bio, Inc. shares withheld for tax at US$0.75 for US$14, leaving 1,615 shares. Filed Apr 27, 2026 (Form 4).
- Withheld for tax
- 19 shares
- Price
- US$0.75
- Value
- US$14
- Holding after
- 1,615 shares
- Trading plan
- No
- Role
- Director, President, CEO and Interim CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 24, 2026 | COMMON STOCK | Shares withheld for tax | 19 | US$0.75 | 1,615 | Direct |
Source
Related
- Mustang Bio, Inc.
- Litchman Manuel MD
- Mustang Bio, Inc. shareholders
- Schedule 13D/A · Fortress Biotech, Inc. · Jan 5, 2026
- Schedule 13D/A · Fortress Biotech, Inc. · Oct 1, 2025
- Schedule 13G/A · Mitchell P. Kopin · Aug 12, 2025
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Schedule 13G/A · Mitchell P. Kopin · May 9, 2025